An Study of Patients With Ph- Chromosome-negative Relapsed or Refractory Acute Lymphoblastic Leukemia in the US

Eltrombopag Olamine in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia

NCT01550185 ·Status: TERMINATED ·Phase: PHASE1

A Study of Nemtabrutinib (MK-1026) in Participants With Relapsed or Refractory Hematologic Malignancies (ARQ 531-101/MK-1026-001)

NCT03162536 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Study of Efficacy and Safety of CTL019 in Adult ALL Patients

NCT02167360 ·Status: WITHDRAWN ·Phase: PHASE2

A Study Of Two Inotuzumab Ozogamicin Doses in Relapsed/ Refractory Acute Lymphoblastic Leukemia Transplant Eligible Patients

NCT03677596 ·Status: COMPLETED ·Phase: PHASE4

Lenalidomide and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

NCT01246622 ·Status: COMPLETED ·Phase: PHASE1

Decitabine, Cytarabine, GCSF for Refractory AML/MDS

NCT00740181 ·Status: TERMINATED ·Phase: PHASE2

Evaluate the Hematological Remission Rates and Survival Among Chinese Adult Patients With B-precursor ALL

NCT03123887 ·Status: COMPLETED

Genotyping Analysis of Acute Lymphoblastic Leukemia

NCT00961285 ·Status: UNKNOWN

A Phase I Study of GNKG168 in Patient With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL)

NCT01035216 ·Status: TERMINATED ·Phase: PHASE1

Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia

NCT00352365 ·Status: COMPLETED ·Phase: PHASE2

Study of Fosciclopirox in Patients With Relapsed/Refractory Acute Myeloid Leukemia

NCT04956042 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Multicenter Study of 9-Aminocamptothecin (9-AC) in Patients With Refractory Leukemia

NCT00251368 ·Status: COMPLETED ·Phase: PHASE1

A Phase I Clinical Trial of OXi4503 for Relapsed and Refractory AML and MDS

NCT01085656 ·Status: TERMINATED ·Phase: PHASE1

Epigenetic Reprogramming in Relapse/Refractory AML

NCT03263936 ·Status: COMPLETED ·Phase: PHASE1

Decitabine and Valproic Acid in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT00079378 ·Status: COMPLETED ·Phase: PHASE1

CPX-351 as a Novel Approach for the Treatment of Older Patients With AML and MDS

NCT04668885 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Revlimid in Patients With Acute Myelogenous Leukemia and Myelodysplastic Syndrome

NCT00360672 ·Status: COMPLETED ·Phase: PHASE2

Risk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

NCT00482352 ·Status: COMPLETED

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

NCT06001788 ·Status: RECRUITING ·Phase: PHASE1

Venetoclax in Addition to Blinatumomab in Adult Patients With Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL)

NCT05182385 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

A Phase II Study of Crenolanib in Relapsed/Refractory Acute Myeloid Leukemia Patients With FLT3 Activating Mutations

NCT01657682 ·Status: COMPLETED ·Phase: PHASE2

A Study of Lenalidomide in Pediatric Subjects With Relapsed or Refractory Acute Myeloid Leukemia

NCT02538965 ·Status: COMPLETED ·Phase: PHASE2

PR104 in Treating Patients With Refractory/Relapsed Acute Leukemia

NCT01037556 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia

NCT02101853 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Phase I/II Study of DFP-10917 in Patients With Acute Leukemia

NCT01702155 ·Status: COMPLETED ·Phase: PHASE1/PHASE2